暗記メーカー
ログイン
Patho Respiratory
  • Two Clean Queens

  • 問題数 100 • 9/28/2023

    記憶度

    完璧

    15

    覚えた

    35

    うろ覚え

    0

    苦手

    0

    未解答

    0

    アカウント登録して、解答結果を保存しよう

    問題一覧

  • 1

    Conducting Airways

    Nose, Pharynx, Larynx, Trachea, Bronchi, Bronchioles

  • 2

    Extra-Thoracic

    Nose, Pharynx, Larynx

  • 3

    Intrathoracic

    Trachea, Bronchi, Bronchioles

  • 4

    Respiratory Zone

    Terminal Bronchi, Alveoli, Aveolar Capillaries

  • 5

    Keeps smooth muscle areas open

    Transpulmonary Pressures

  • 6

    Factors that relax smooth muscles in bronchi and bronchioles

    Sympathetic (Beta-2 and Epi)

  • 7

    Contraction of bronchiolar smooth muscle and bronchoconstriction

    Parasympathetic from vagas nerve releasing acetylcholine

  • 8

    Contraction of bronchiolar smooth muscle and bronchoconstriction

    Release of leukotrines and histamine from lung cells and endothelium

  • 9

    Contraction of bronchiolar smooth muscle and bronchoconstriction

    Histamine released from mast cells

  • 10

    Small changes in diameter increases difficulty of breathing

    Airway Resistance

  • 11

    Increases suction pulling lungs with ribs (normally -5, when chest expands decreases to -7.5)

    Pleural Pressure

  • 12

    Measure pressure of respiratory tree when glottis is open = atmospheric pressure (0 cm H2O)

    Alveolar Pressure

  • 13

    Alveolar Pressure

    Chest expansion (-1) air moves in. Chest recoil (+1) air moves out.

  • 14

    Difference between pleural and alveolar pressures

    Transpulmonary Pressure

  • 15

    Elastic forces that cause lung collapse at end of exhalation are counteracted by PEEP, surfactant, and closed glottis

    Transpulmonary Pressure

  • 16

    Breach of pleural spaces, air gets trapped, lung can’t expand because pleural space becomes equivalent to alveolar/atmospheric pressure (change from -4 to 0 mmHg)

    Pneumothorax

  • 17

    Patient comes in to the clinic with dyspnea, tachycardia, deviated trachea, decreased breath sounds on affected side, hyperresonance to percussion.

    Pneumothorax

  • 18

    Increased Resistance Curve

    Asthma and COPD

  • 19

    Decreased Compliance Curve

    PNE and Pulmonary Edema

  • 20

    Channels between alveoli to allow communication. Implicated in alveolar diseases and ease of spread of pulmonary infections.

    Pores of Kohn and Canal of Lambert

  • 21

    Coats inner alveoli and allows expansion during inhalation and prevents alveolar collapse on exhalation.

    Surfactant

  • 22

    Contraction pulls lungs down during inhalation and relaxation/elastic recoil moves lungs up during exhalation

    Diaphram

  • 23

    Raise and expand rib cage with help of sternocleidomastoid muscles on inhalation

    External intercostals

  • 24

    Pulls rib cage down and in during exhalation

    Internal intercostals and abdominal recti

  • 25

    Tissue lining the lungs and rib cage

    Pleura

  • 26

    Tissue lining the lungs

    Visceral Pleura

  • 27

    Tissue lining the rib cage

    Parietal Pleura

  • 28

    Fills the space between the visceral and parietal pleura

    Pleural fluid

  • 29

    Degree lungs expand per unit of change in transpulmonary pressure and determined by elastic forces in lung tissue, alveoli, lung interstitum, and pleural tension

    Lung compliance

  • 30

    Air-fluid interface creates a force that causes the alveoli to collapse inward

    Surface tension elastic force

  • 31

    Alveoli are lined with small amounts of fluid - water molecules of alveolar fluid are attracted to water molecules in the air

    Contractile force

  • 32

    Reduces the surface tension and disrupts the water molecules

    Surfactant

  • 33

    There is greater muscular effort needed to expand the thorax and chest wall has limited recoil

    Rigidity of mature rib cage

  • 34

    The chest wall is less rigid and easier to expand but has strong recoil and more potential for collapse during exhalation

    Cartilaginous ribs of children

  • 35

    Lung compliance is decreased with

    Pulmonary edema or infection

  • 36

    Chest wall compliance is decreased

    Scoliosis and obesity

  • 37

    Airways are obstructed

    Bronchospasm or mucous plugging

  • 38

    Volume of inspired and expired air with each breath

    Tidal volume

  • 39

    Maxium extra volume of air that can be inspired at the end of a normal volume

    Inspiratory reserve volume

  • 40

    Maximum extra volume of air that can be expired at the end of a normal tidal volume

    Expiratory reserve volume

  • 41

    Tidal volume + Inspiratory reserve volume

    Inspiratory capacity

  • 42

    Expiratory reserve volume + residual volume (amount of air that remains at the end of normal exhalation)

    Functional residual capacity

  • 43

    Inspiratory reserve volume + tidal volume + expiratory reserve volume (maximum volume that can be exhaled after maximum inhale)

    Vital capacity

  • 44

    Vital capacity + residual volume (maximum volume lung can be expanded)

    Total lung capacity

  • 45

    Tidal volume x respiratory rate

    Minute ventilation

  • 46

    The rate air reaches the gas-exchange areas of the lungs via diffusion

    Alveolar ventilation

  • 47

    Space in respiratory system where no gas exchange occurs (alveoli without blood flow)

    Dead space

  • 48

    Anatomic dead space + alveoli without blood flow

    Physiologic dead space

  • 49

    Conducting zones = 30% of total lung capacity

    Anatomic dead space

  • 50

    Causes CO2 trapping

    Dead spaces

  • 51

    Anatomy of Pulmonary Circulation

    RV—>Pulmonary Artery—>Pulmonary Capillary Bed—>Pulmonary Vein—>LA

  • 52

    From systemic circulation, provide oxygenated blood to trachea, bronchi, esophagus, visceral pleural and pulmonary arteries but doesn’t contribute to gas exchange

    Bronchial vessels

  • 53

    Balance between alveolar ventilation and alveolar blood flow

    V/Q matching

  • 54

    When V/Q mismatched there will be differences between

    Alveolar O2 and PaO2, ETCO2 and PaCO2

  • 55

    PaO2 will be normal if

    Patient has lung disease and intact V/Q because body has shunted blood to alveoli that are perfused

  • 56

    V/Q is below normal = inadequate ventilation to oxygenate blood flowing through alveolar capillaries. Inability to shunt blood to alveoli that are perfused.

    Physiologic shunting

  • 57

    V/Q is above normal = alveoli are well ventilated but there are alveoli that are not well perfused. Something is blocking blood flow to these alveoli.

    Physiologic dead space

  • 58

    No blood flow (capillary pressure < alveolar pressure)

    Zone I

  • 59

    Intermittent blood flow (with peak pulmonary capillary pressure > alveolar pressure…diastolic capillary pressure < alveolar pressure)

    Zone II

  • 60

    Continuous blood blow (capillary pressure > alveolar pressure)

    Zone III

  • 61

    Blood flow occurs when PA pressures are too high (R HF or RVOT obstruction) or alveolar pressure too high (hyperinflation)

    Zone I

  • 62

    During exercise (increased CO) all areas of lungs get

    Zone III

  • 63

    Pressure in pulmonary capillaries

    Low, 7mmHg

  • 64

    Interstitial fluid pressures

    Negative, -5 to -8 mmHg

  • 65

    Net fluid movement from alveoli to interstitial space —> drains into lymphatics (keeps alveoli free of excess fluid)

    Mean filtration pressure

  • 66

    Excess fluid in the alveoli impairing gas exchange and decreasing lung compliance

    Pulmonary edema

  • 67

    Increased left heart pressures, pulmonary over-circulation, increased pulmonary capillary permeability (inflammation)

    Causes of pulmonary edema

  • 68

    Mucoid fluid in the pleural space that contributes to negative intrapleural pressure that prevents pulmonary edema

    Pleural fluid

  • 69

    Excess fluid in pleural space

    Pleural effusion

  • 70

    Blocked lymph drainage, LHF, Reduced Plasma Oncotic Pressure (causes increased fluid accumulation), Increased Permeability Membrane (inflammation)

    Causes of Pleural Effusion

  • 71

    Normal SpO2 range

    97-100%

  • 72

    SvO2 normal range

    75%

  • 73

    CO2 is bound to hemoglobin and transported (Carboxyhemoglobin), transport is bicarbonate, combines with blood protein (carbamino compounds), oxygen in alveoli displaces CO2 on Hbg promoting CO2 removal (Haldane effect) and ventilated out of the body

    CO2 Transport

  • 74

    Groups of Medulla

    Dorsal and Ventral

  • 75

    Brain stem center controls Inspiration

    Dorsal

  • 76

    Brain stem center controls exhalation

    Ventral

  • 77

    Pneumotaxic center - controls breathing rate and pattern

    Pons

  • 78

    Vagal and glossopharyngeal nerves end in the medulla. Transmit signals from chemoreceptors and baroreceptors. Send signals to diaphram and intercostal muscles to controls rate of breathing and inspiration time

    Dorsal respiratory neurons

  • 79

    Inactive during normal breathing, fire during hypoventilation and signal inspiration, stimulate abdominal muscle contraction for forceful exhalation

    Ventral respiratory neurons

  • 80

    Neurons in medulla, sense changes in pH of CSF, mechanism detects small changes in CO2 (1-2 mmHg), changes rate and depth and respirations

    Central Chemoreceptors

  • 81

    Chronic condition that can make central chemoreceptors less sensitive by increasing bicarbonate

    COPD

  • 82

    This molecule crosses BBB to combine with H2O to create bicarbonate

    CO2

  • 83

    Chemoreceptors in carotid and aortic bodies that sense changes in O2 concentration. Decreased PaO2 levels will increase respiratory rate.

    Peripheral chemoreceptors

  • 84

    Found in epithelium of conducting airways, sensitive to aerosols, gases, particles (induces cough) increases respiratory rate and can lead to Bronchospasm

    Irritation receptors

  • 85

    When smooth muscle in bronchi, bronchioles, or lung parenchyma stretched —> signal medulla dorsal respiratory neurons to switch off Inspiration (Hering-Breuer Inflation Reflex)

    Stretch receptors

  • 86

    Respond to increased pulmonary capillary pressures (eg LHF) —> initiate rapid, shallow breathing, causes laryngeal vasoconstriction and mucous secretion

    Pulmonary C-Receptors (J receptors)

  • 87

    Vasoconstriction to area of lung, decreased surfactant, high V/Q mismatch. Diagnosis - tachypnea, dyspnea, chest pain, hypoxia, pulmonary edema and atelectasis, pulmonary infarct and pulmonary HTN, decreased CO, elevated D-dimer (early test), CTA or MRA tests (confirm diagnosis), EKG changes with right strain, troponin level to help stratify risk of adverse outcomes. Treatment- fibrinolytics

    Pulmonary embolism

  • 88

    Pulmonary artery pressure > 25 mmHg, associated with chronic hypoxia, LHF, valve disease causing dyspnea, chest pain,tachypnea, cough, JVD

    PAH

  • 89

    Causes (idiopathic, genetic, connective tissue disease). Pathophysiology (vasoconstrictors overwhelm pulmonary vasodilators —> resistance of blood flow to lungs —> RV remodeling —> Cor Pulmonale (RHF)

    Pulmonary Artery Hypertension

  • 90

    Hallmarks: Worse on expiration —> prolonged expiratory phase and decreased FEV. Dyspnea. Wheezing (lower airways) and Stridor (upper airways)

    Obstructive Lung Disease

  • 91

    Chronic inflammatory disease of bronchial mucosa causing hyperresponsiveness, bronchoconstriction, and obstruction

    Asthma

  • 92

    Antigen exposure —> cytokine response —> increased capillary permeability, mucosal edema and production, Bronchospasm

    Early Asthma Response

  • 93

    Inflammatory mediators —> Bronchospasm —> secretions —> obstruction—> air trapping —> hyperinflation —> V/Q mismatch —> hypoxemia —> CO2 retention —> acidosis —> respiratory failure

    Late Response Asthma

  • 94

    Treatment: Beta2 (albuterol), Anticholinergics, Steroids, and Antihistamines

    Asthma

  • 95

    Airflow obstruction that is not fully reversible and generally progressive. Generally, “acquired” but some genetic basis (alpha1-anti-trypsin deficiency)

    COPD

  • 96

    Hypersecretion of mucus and chronic productive cough (3months/yr for 2+ yrs). Initially impacts large airways but ultimately affects all bronchial smooth muscle. Bronchial inflammation—> edema—> increased size and number of mucosal cells and goblet cells—> air trapping on expiration. V/Q mismatch—> hypoxemia—>mild cyanosis. Dyspnea on exertion. Chronic hypercarbia.

    Chronic Bronchitis

  • 97

    Enlargement of respiratory airways and destruction of alveolar zones. Breakdown of elastin —> loss of elastic recoil —> air trapping —> dyspnea —> hypoventilation —> hypercarbia. Structural changes (loss of alveolar cells) —> increased area for gas exchange + bullae and blebs —> V/Q mismatch —> hypoxemia. Systemic effects of chronic inflammation —> malnutrition and infection risk

    Emphysema

  • 98

    Productive cough (classic sign), dyspnea (late in course), wheezing (intermittent), barrel chest (occasionally), prolonged exhalation (always), Cyanosis (common), chronic hypoventilation (common), Cor Pulmonale (common)

    Chronic Bronchitis

  • 99

    Productive cough (late in course), dyspnea (common), wheezing (minimal), barrel chest (classic sign), prolonged exhalation (always), Cyanosis (uncommon), chronic hypoventilation (late in course), Cor Pulmonale (late in course)

    Emphysema

  • 100

    Caused from acute viral infection. Subglottic edema causes narrowing of airway and respiratory distress develops into barky cough and stridor

    Croup